At what dose should I start mirtazapine for appetite stimulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine Dosing for Appetite Stimulation

For appetite stimulation, start mirtazapine at 15 mg once daily, administered orally in the evening prior to sleep. 1, 2

Initial Dosing and Administration

  • The FDA-approved starting dose of mirtazapine is 15 mg once daily, preferably taken in the evening before bedtime 1
  • This dosage is effective for appetite stimulation while minimizing daytime sedation 3
  • Low-dose mirtazapine (15 mg) is particularly effective for appetite stimulation while limiting side effects 2
  • Some patients may respond to doses as low as 7.5 mg (half of a 15 mg tablet), especially elderly patients or those sensitive to sedation 4

Dose Titration

  • If inadequate response after 1-2 weeks, the dose may be increased to 30 mg daily 1
  • Maximum dose is 45 mg daily, though appetite stimulation effects are often achieved at lower doses 1
  • Allow 1-2 weeks between dose adjustments to properly evaluate response 1
  • Higher doses don't necessarily provide better appetite stimulation but may increase side effects 2

Monitoring Response

  • Assess appetite improvement and meal intake within 1-2 weeks of initiation 5
  • Monitor weight weekly to evaluate effectiveness 2
  • Evaluate for side effects, particularly excessive sedation, which may limit daytime functioning 2, 6
  • If no improvement in appetite is seen after 2-4 weeks of therapy at an adequate dose, consider alternative agents 2

Common Side Effects to Monitor

  • Drowsiness/sedation (23% vs 14% with placebo) 6
  • Dry mouth (25% vs 16% with placebo) 6
  • Increased appetite (11% vs 2% with placebo) - this is the desired effect 6
  • Weight gain (10% vs 1% with placebo) 6
  • Dizziness 7

Important Considerations

  • Mirtazapine has shown effectiveness for appetite stimulation in hospitalized patients with a mean improvement in meal intake of 17.12% 5
  • The medication should not be discontinued abruptly, as this can lead to discontinuation syndrome including anxiousness, nausea, tremor, and loss of appetite 8
  • If discontinuation is needed, gradually taper the dose rather than stopping abruptly 1, 8
  • Mirtazapine can be particularly useful for patients with concomitant sleep difficulties or mood disorders 3

Precautions

  • Screen for bipolar disorder before initiating treatment 1
  • Allow at least 14 days between discontinuing MAOIs and starting mirtazapine 1
  • Dose adjustments may be needed with strong CYP3A inducers or inhibitors 1
  • Monitor for rare but serious hematological changes (e.g., agranulocytosis) 6
  • Use with caution in patients with hepatic or renal insufficiency 6

Mirtazapine's unique mechanism as a noradrenergic and specific serotonergic antidepressant (NaSSA) makes it effective for appetite stimulation through its antagonism of central α2-adrenergic receptors and serotonin 5-HT2 and 5-HT3 receptors 6, 7. This pharmacological profile contributes to its effectiveness in improving appetite while also providing potential benefits for sleep and mood.

References

Guideline

Appetite Stimulation in Patients with Decreased Appetite

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Low-dose mirtazapine improved nausea and appetite loss during S-1 therapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 2012

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Research

The Hunger for Mirtazapine: A Discontinuation Syndrome.

Journal of pain & palliative care pharmacotherapy, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.